| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 35.24 mm | 35.24 mm | 35.24 mm | 35.24 mm | 35.24 mm | 35.24 mm |
| Cash burn (monthly) | 11.71 mm | 3.59 mm | 8.15 mm | 6.57 mm | 7.81 mm | 5.48 mm |
| Cash used (since last report) | 59.31 mm | 18.16 mm | 41.25 mm | 33.26 mm | 39.57 mm | 27.73 mm |
| Cash remaining | -24.07 mm | 17.08 mm | -6.01 mm | 1.98 mm | -4.33 mm | 7.50 mm |
| Runway (months of cash) | -2.1 | 4.8 | -0.7 | 0.3 | -0.6 | 1.4 |
| 13F holders | Current |
|---|---|
| Total holders | 106 |
| Opened positions | 22 |
| Closed positions | 13 |
| Increased positions | 40 |
| Reduced positions | 22 |
| 13F shares | Current |
|---|---|
| Total value | 461.40 bn |
| Total shares | 26.96 mm |
| Total puts | 11.90 k |
| Total calls | 4.30 k |
| Total put/call ratio | 2.8 |
| Largest owners | Shares | Value |
|---|---|---|
| Ra Capital Management | 2.54 mm | $51.49 bn |
| Avoro Capital Advisors | 2.22 mm | $45.07 bn |
| BlackRock | 1.80 mm | $36.58 bn |
| Hydra | 1.70 mm | $0.00 |
| TCG Crossover GP I | 1.48 mm | $56.89 mm |
| TCG Crossover Management | 1.48 mm | $29.97 bn |
| PFE Pfizer | 1.27 mm | $25.80 bn |
| Vanguard | 1.11 mm | $22.43 bn |
| Blue Owl Capital | 1.08 mm | $21.89 bn |
| Jennison Associates | 845.80 k | $17.15 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | Sandeep Chidambar Kulkarni | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 15.54 | 226,000 | 3.51 mm | 226,000 |
| 27 Jan 25 | Ryan F. Robinson | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 27 Jan 25 | Middlekauff W Bradford | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 27 Jan 25 | Susan Dana Jones | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
| 27 Jan 25 | Kevin Bruce Johnson | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 58,000 | 986.00 k | 58,000 |
